Literature DB >> 26518128

Immunotherapeutic effects of chitin in comparison with chitosan against Leishmania major infection.

Mostafa Haji Molla Hoseini1, Maryam Moradi2, Mohammad Hossein Alimohammadian3, Vahid Khaze Shahgoli3, Hayedeh Darabi3, Ali Rostami4.   

Abstract

Chitin and chitosan microparticles (MPs) are important immune system stimulators. The aim of this study was to evaluate the protective effects of these compounds in comparison with each other against Leishmania infection in BALB/c mice infected with Leishmania major (L. major). Female BALB/c mice were injected subcutaneously with 2×10(5) promastigotes. Chitin and/or chitosan MPs (<40 μm) were subcutaneously injected in the BALB/c mice with two-day intervals until two weeks. Mice in all groups were sacrificed at 12 weeks post-infection. Enumeration of viable parasites was performed using limiting dilution assay. Furthermore, the animals (5 mice/group) were sacrificed two weeks post-infection. The lymph node cells were isolated and the effects of the chitinous MPs on the proliferation and production of cytokines such as tumor necrosis factor alpha (TNF-α) and interleukin-10 (IL-10) were determined. The mean sizes of lesions were significantly smaller in chitin (0.6±0.12 mm) and chitosan treated groups (1.2±0.8 mm) than in the control group (6.2±1.7 mm) (P<0.05). The parasite load in the lymph nodes of the treated mice was significantly lower than that in the lymph nodes of controls (1.31×10(6) vs 8.24×10(7) parasite/lymph node [P=0.032] and 7.49×10(6) vs 8.24×10(7) parasite/lymph node [P=0.05] for chitin and chitosan MPs treatment, respectively). We found that chitinous MPs induced cell proliferation and that chitin but not chitosan increased TNF-α and IL-10 production. Chitin appears that it has more effect than chitosan against leishmaniasis. The current study revealed that chitinous MPs had significant activity against L. major and could be considered as new therapeutic modality in leishmaniasis.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Chitin; Chitosan; Immunotherapeutic effect; Leishmania major

Mesh:

Substances:

Year:  2015        PMID: 26518128     DOI: 10.1016/j.parint.2015.10.007

Source DB:  PubMed          Journal:  Parasitol Int        ISSN: 1383-5769            Impact factor:   2.230


  12 in total

1.  Chitosan-based nano-scaffolds as antileishmanial wound dressing in BALB/c mice treatment: Characterization and design of tissue regeneration.

Authors:  Seyyed Javad Seyyed Tabaei; Mohsen Rahimi; Mohsen Akbaribazm; Seyed Ali Ziai; Minoo Sadri; Seyed Reza Shahrokhi; Mitra Sadat Rezaei
Journal:  Iran J Basic Med Sci       Date:  2020-06       Impact factor: 2.699

2.  Anti-Leishmanial Effects of Chitosan-Polyethylene Oxide Nanofibers Containing Berberine: An Applied Model for Leishmania Wound Dressing.

Authors:  Mohsen Rahimi; Seyyed Javad Seyyed Tabaei; Seyed Ali Ziai; Minoo Sadri
Journal:  Iran J Med Sci       Date:  2020-07

3.  Preliminary Study on Gene Expression of Chitinase-Like Cytokines in Human Airway Epithelial Cell Under Chitin and Chitosan Microparticles Treatment.

Authors:  Masumeh Alimohammadi; Farshid Yeganeh; Mostafa Haji Molla Hoseini
Journal:  Inflammation       Date:  2016-06       Impact factor: 4.092

Review 4.  Alternative to Chemotherapy-The Unmet Demand against Leishmaniasis.

Authors:  Nicky Didwania; Md Shadab; Abdus Sabur; Nahid Ali
Journal:  Front Immunol       Date:  2017-12-21       Impact factor: 7.561

5.  Activity of Chitosan and Its Derivatives against Leishmania major and Leishmania mexicana In Vitro.

Authors:  Alaa Riezk; John G Raynes; Vanessa Yardley; Sudaxshina Murdan; Simon L Croft
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

6.  Comparative analysis between four model nanoformulations of amphotericin B-chitosan, amphotericin B-dendrimer, betulinic acid-chitosan and betulinic acid-dendrimer for treatment of Leishmania major: real-time PCR assay plus.

Authors:  Ali Khamesipour; Amitis Ramezani; Tahereh Zadeh Mehrizi; Mehdi Shafiee Ardestani; Hasan Ebrahimi Shahmabadi; Mostafa Haji Molla Hoseini; Nariman Mosaffa
Journal:  Int J Nanomedicine       Date:  2019-09-24

7.  Antimicrobial Activity of Chitosan Oligosaccharides with Special Attention to Antiparasitic Potential.

Authors:  Nayara Sousa da Silva; Nathália Kelly Araújo; Alessandra Daniele-Silva; Johny Wysllas de Freitas Oliveira; Júlia Maria de Medeiros; Renata Mendonça Araújo; Leandro De Santis Ferreira; Hugo Alexandre Oliveira Rocha; Arnóbio Antônio Silva-Junior; Marcelo Sousa Silva; Matheus de Freitas Fernandes-Pedrosa
Journal:  Mar Drugs       Date:  2021-02-12       Impact factor: 5.118

8.  In Vitro Studies Toward the Use of Chitin as Nutraceutical: Impact on the Intestinal Epithelium, Macrophages, and Microbiota.

Authors:  Liyou Dong; Renata M C Ariëns; Monic M Tomassen; Harry J Wichers; Coen Govers
Journal:  Mol Nutr Food Res       Date:  2020-10-16       Impact factor: 5.914

9.  Detection of Potentially Diagnostic Leishmania Antigens with Western Blot Analysis of Sera from Patients with Cutaneous and Visceral Leishmaniases.

Authors:  Seyyed Javad Seyyedtabaei; Ali Rostami; Ali Haghighi; Mehdi Mohebali; Bahram Kazemi; Shirzad Fallahi; Adel Spotin
Journal:  Iran J Parasitol       Date:  2017 Apr-Jun       Impact factor: 1.012

Review 10.  Chitosan Contribution to Therapeutic and Vaccinal Approaches for the Control of Leishmaniasis.

Authors:  Philippe M Loiseau; Sébastien Pomel; Simon L Croft
Journal:  Molecules       Date:  2020-09-09       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.